InSightec Ltd. announced that the first U.S. patient has been treated in the company's pivotal trial to evaluate the safety and effectiveness of the non-invasive, radiation-free ExAblate(R) Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system as a pain relieving treatment for patients with bone metastases who have failed an initial round of palliative radiation. ...
Anytime
